Christine Buttorff, PhD

home / authors / christine-buttorff-phd

Articles

January 3rd 2022

Projected US Savings From Biosimilars, 2021-2025

Andrew Mulcahy, PhD, MPP Christine Buttorff, PhD Kenneth Finegold, PhD Zeid El-Kilani, MPP Jon F. Oliver, PhD Stephen Murphy, PhD Amber Jessup, PhD

Projected savings from biosimilars from 2021 to 2025 were $38.4 billion vs conditions as of quarter 4 of 2020 and were driven by new biosimilar entry. Savings were $124.5 billion under an upper-bound scenario.

November 13th 2020

Variation in Generic Dispensing Rates in Medicare Part D

Christine Buttorff, PhD Yifan Xu, PhD Geoffrey Joyce, PhD

Generic use has increased over time in Medicare Part D, but substantial variation across plans persists in a number of common classes.

July 18th 2019

Insurers’ Perspectives on MA Value-Based Insurance Design Model

Dmitry Khodyakov, PhD Christine Buttorff, PhD Kathryn Bouskill, PhD Courtney Armstrong, MPH Sai Ma, PhD Erin Audrey Taylor, PhD Christine Eibner, PhD

This article describes perspectives of Medicare Advantage (MA) insurers about participating in the CMS value-based insurance design model test launched in 2017.

June 5th 2015

Innovative Care Models for High-Cost Medicare Beneficiaries: Delivery System and Payment Reform to Accelerate Adoption

Karen Davis, PhD, APN Christine Buttorff, PhD Bruce Leff, MD Quincy M. Samus, PhD Sarah Szanton, PhD, APN Jennifer L. Wolff, PhD Farhan Bandeali, MSPH

This paper illustrates how Medicare Advantage plans and accountable care organizations could benefit from adopting innovative care delivery models, and suggests policy changes to accelerate spread.